| 1 | reactions | 8,082 |
| 2 | multiforme | 89 |
| 3 | eruptions | 74 |
| 4 | sensitizations | 21 |
| 5 | differentiation-associated | 13 |
| 6 | accusations | 10 |
| 7 | effects.the | 4 |
| 8 | oncolysate | 4 |
| 9 | intolerabilities | 3 |
| 10 | bag+peer | 2 |
| 11 | cavernosometry/cavernosography | 2 |
| 12 | effects.we | 2 |
| 13 | epithelitis | 2 |
| 14 | kardex | 2 |
| 15 | survivor-centered | 2 |
| 16 | 1046-38 | 1 |
| 17 | 16d | 1 |
| 18 | 31cgpc34 | 1 |
| 19 | acna | 1 |
| 20 | administration-intake | 1 |
| 21 | albopunctatus | 1 |
| 22 | auaagu | 1 |
| 23 | betsileo | 1 |
| 24 | budesonid | 1 |
| 25 | carriers.the | 1 |
| 26 | cells-that | 1 |
| 27 | cells/lysates | 1 |
| 28 | concentration.the | 1 |
| 29 | cys-163 | 1 |
| 30 | d1,8 | 1 |
| 31 | dermatitides | 1 |
| 32 | effects-grade | 1 |
| 33 | effects.- | 1 |
| 34 | effects.astragalus | 1 |
| 35 | events-most | 1 |
| 36 | events.54 | 1 |
| 37 | events.ty21a | 1 |
| 38 | events.very | 1 |
| 39 | fell-out | 1 |
| 40 | guaugu | 1 |
| 41 | hyperextensibility | 1 |
| 42 | inflammation-promotion | 1 |
| 43 | intake.the | 1 |
| 44 | interactions-and | 1 |
| 45 | involvement/symptoms | 1 |
| 46 | lability/impulsivity | 1 |
| 47 | laparocator | 1 |
| 48 | le�n | 1 |
| 49 | liking-suggesting | 1 |
| 50 | manax | 1 |
| 51 | medi-honey | 1 |
| 52 | multiform-patients | 1 |
| 53 | multiformes | 1 |
| 54 | patients.euramos-1 | 1 |
| 55 | pcmv-mthsp70-ires-tk | 1 |
| 56 | phosphoser99 | 1 |
| 57 | reaction-related | 1 |
| 58 | reactions.the | 1 |
| 59 | reactions/inflammation | 1 |
| 60 | rhinitis-conjunctivitis | 1 |
| 61 | rhinoconjuntivitis | 1 |
| 62 | sonohysteroscopy | 1 |
| 63 | study-iv | 1 |
| 64 | subcontracted | 1 |
| 65 | symptoms.adolescents | 1 |
| 66 | tarapacana | 1 |
| 67 | test-easy | 1 |
| 68 | visits/month/user | 1 |
| 1 | 1046-38 | 1 |
| 2 | 16d | 1 |
| 3 | 31cgpc34 | 1 |
| 4 | accusations | 10 |
| 5 | acna | 1 |
| 6 | administration-intake | 1 |
| 7 | albopunctatus | 1 |
| 8 | auaagu | 1 |
| 9 | bag+peer | 2 |
| 10 | betsileo | 1 |
| 11 | budesonid | 1 |
| 12 | carriers.the | 1 |
| 13 | cavernosometry/cavernosography | 2 |
| 14 | cells-that | 1 |
| 15 | cells/lysates | 1 |
| 16 | concentration.the | 1 |
| 17 | cys-163 | 1 |
| 18 | d1,8 | 1 |
| 19 | dermatitides | 1 |
| 20 | differentiation-associated | 13 |
| 21 | effects-grade | 1 |
| 22 | effects.- | 1 |
| 23 | effects.astragalus | 1 |
| 24 | effects.the | 4 |
| 25 | effects.we | 2 |
| 26 | epithelitis | 2 |
| 27 | eruptions | 74 |
| 28 | events-most | 1 |
| 29 | events.54 | 1 |
| 30 | events.ty21a | 1 |
| 31 | events.very | 1 |
| 32 | fell-out | 1 |
| 33 | guaugu | 1 |
| 34 | hyperextensibility | 1 |
| 35 | inflammation-promotion | 1 |
| 36 | intake.the | 1 |
| 37 | interactions-and | 1 |
| 38 | intolerabilities | 3 |
| 39 | involvement/symptoms | 1 |
| 40 | kardex | 2 |
| 41 | lability/impulsivity | 1 |
| 42 | laparocator | 1 |
| 43 | le�n | 1 |
| 44 | liking-suggesting | 1 |
| 45 | manax | 1 |
| 46 | medi-honey | 1 |
| 47 | multiform-patients | 1 |
| 48 | multiforme | 89 |
| 49 | multiformes | 1 |
| 50 | oncolysate | 4 |
| 51 | patients.euramos-1 | 1 |
| 52 | pcmv-mthsp70-ires-tk | 1 |
| 53 | phosphoser99 | 1 |
| 54 | reaction-related | 1 |
| 55 | reactions | 8,082 |
| 56 | reactions.the | 1 |
| 57 | reactions/inflammation | 1 |
| 58 | rhinitis-conjunctivitis | 1 |
| 59 | rhinoconjuntivitis | 1 |
| 60 | sensitizations | 21 |
| 61 | sonohysteroscopy | 1 |
| 62 | study-iv | 1 |
| 63 | subcontracted | 1 |
| 64 | survivor-centered | 2 |
| 65 | symptoms.adolescents | 1 |
| 66 | tarapacana | 1 |
| 67 | test-easy | 1 |
| 68 | visits/month/user | 1 |
| 1 | effects.- | 1 |
| 2 | patients.euramos-1 | 1 |
| 3 | cys-163 | 1 |
| 4 | 31cgpc34 | 1 |
| 5 | events.54 | 1 |
| 6 | d1,8 | 1 |
| 7 | 1046-38 | 1 |
| 8 | phosphoser99 | 1 |
| 9 | events.ty21a | 1 |
| 10 | tarapacana | 1 |
| 11 | acna | 1 |
| 12 | 16d | 1 |
| 13 | survivor-centered | 2 |
| 14 | differentiation-associated | 13 |
| 15 | reaction-related | 1 |
| 16 | subcontracted | 1 |
| 17 | budesonid | 1 |
| 18 | interactions-and | 1 |
| 19 | effects-grade | 1 |
| 20 | intake.the | 1 |
| 21 | concentration.the | 1 |
| 22 | reactions.the | 1 |
| 23 | carriers.the | 1 |
| 24 | effects.the | 4 |
| 25 | administration-intake | 1 |
| 26 | multiforme | 89 |
| 27 | oncolysate | 4 |
| 28 | effects.we | 2 |
| 29 | liking-suggesting | 1 |
| 30 | pcmv-mthsp70-ires-tk | 1 |
| 31 | reactions/inflammation | 1 |
| 32 | inflammation-promotion | 1 |
| 33 | le�n | 1 |
| 34 | betsileo | 1 |
| 35 | bag+peer | 2 |
| 36 | visits/month/user | 1 |
| 37 | laparocator | 1 |
| 38 | dermatitides | 1 |
| 39 | intolerabilities | 3 |
| 40 | multiformes | 1 |
| 41 | cells/lysates | 1 |
| 42 | epithelitis | 2 |
| 43 | rhinitis-conjunctivitis | 1 |
| 44 | rhinoconjuntivitis | 1 |
| 45 | involvement/symptoms | 1 |
| 46 | accusations | 10 |
| 47 | sensitizations | 21 |
| 48 | reactions | 8,082 |
| 49 | eruptions | 74 |
| 50 | symptoms.adolescents | 1 |
| 51 | multiform-patients | 1 |
| 52 | effects.astragalus | 1 |
| 53 | albopunctatus | 1 |
| 54 | cells-that | 1 |
| 55 | events-most | 1 |
| 56 | fell-out | 1 |
| 57 | auaagu | 1 |
| 58 | guaugu | 1 |
| 59 | study-iv | 1 |
| 60 | manax | 1 |
| 61 | kardex | 2 |
| 62 | medi-honey | 1 |
| 63 | cavernosometry/cavernosography | 2 |
| 64 | sonohysteroscopy | 1 |
| 65 | events.very | 1 |
| 66 | test-easy | 1 |
| 67 | hyperextensibility | 1 |
| 68 | lability/impulsivity | 1 |